Peripheral Vascular Disease and Outcomes Following Coronary Artery Bypass Graft Surgery | Cardiology | JAMA Surgery | JAMA Network
[Skip to Navigation]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address Please contact the publisher to request reinstatement.
Criqui  MHLanger  RDFronek  A A mortality over a period of ten years in patients with peripheral arterial disease.  N Engl J Med 1992;326381- 386PubMedGoogle ScholarCrossref
Birkmeyer  JDO’Connor  GTQuinton  HB  et al.  The effect of peripheral vascular disease on in-hospital mortality rates with coronary artery bypass surgery.  J Vasc Surg 1995;21445- 452PubMedGoogle ScholarCrossref
Birkmeyer  JDQuinton  HBO’Connor  NJ  et al.  The effect of peripheral vascular disease on long-term mortality after coronary artery bypass surgery.  Arch Surg 1996;131316- 321PubMedGoogle ScholarCrossref
Kaul  TKFields  BLWyatt  DAJones  CRKahn  DR Surgical management in patients with coexistent coronary and cerebrovascular disease: long-term results.  Chest 1994;1061349- 1357PubMedGoogle ScholarCrossref
Loponen  PTaskinen  PLaakkonen  E  et al.  Peripheral vascular disease as predictor of outcome after coronary artery bypass grafting.  Scand J Surg 2002;91160- 165PubMedGoogle Scholar
Original Article
December 1, 2006

Peripheral Vascular Disease and Outcomes Following Coronary Artery Bypass Graft Surgery

Author Affiliations

Author Affiliations: Department of Surgery, Good Samaritan Hospital (Drs Collison and Smith), Cardiac, Vascular, and Thoracic Surgery, Inc (Dr Smith), and E. Kenneth Hatton, MD, Institute for Research and Education, Cincinnati, Ohio (Ms Engel).

Arch Surg. 2006;141(12):1214-1218. doi:10.1001/archsurg.141.12.1214

Hypothesis  There is an increased operative risk in patients with a history of peripheral vascular disease (PVD) who undergo coronary artery bypass grafting (CABG). There are also outcome differences associated with these patients.

Design  A study from a 10-year hospitalization cohort with prospective data collection.

Setting  Multiple hospitals in the Greater Cincinnati area with 1 surgical group of cardiac surgeons.

Participants  Cases were CABG patients with PVD, which was defined as having a history of type 1 neurologic injury, prior vascular surgery, or current vascular disease (n = 1561). Controls were CABG patients without PVD (n = 6328).

Interventions  The study examined 42 potential confounding risk factors and 16 outcome variables.

Results  Twenty-nine potential risk factors were found to be significantly different between CABG patients with and without PVD. Twenty-six confounding risk factors were correlated with 3 factors. Logistic regression analysis showed that even after controlling for sex, significant associative disorders, and other procedures, CABG patients with PVD still experienced more arrhythmias requiring treatment (odds ratio [OR], 1.7; 95% confidence interval [CI], 1.03-1.33; P = .01), neurological complications (OR, 1.7; 95% CI, 1.43-2.07; P<.001), pulmonary complications (OR, 1.4; 95% CI, 1.23-1.62; P<.001), low output (OR, 1.3; 95% CI, 1.09-1.45; P = .001), and intraoperative complications (OR, 1.39; 95% CI, 1.06-1.83; P = .02).

Conclusions  Patients with a PVD history undergoing CABG had more coexistent risk factors. These patients also exhibited higher rates of cardiac, systemic, renal, neurologic, and pulmonary complications.